FOLLOW US

  • facebook
  • twitter
Wed

March 17, 2026

Day One to acquire Mersana Therapeutics

America November 14, 2025

Day One to Acquire Mersana Therapeutics in High-Stakes $285M Cancer Drug Deal

In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…

By Rihem Akkouche

Cellectis, AstraZeneca IP Suit

America September 27, 2025

Cellectis, AstraZeneca Hit with IP Suit Over Gene-Editing Technology

A Massachusetts-based biotech says two pharmaceutical giants are trampling its intellectual property. Factor Bioscience Inc. filed suit Friday in Delaware…

By Rihem Akkouche

AbbieVie Buys ImmunoGen

America November 30, 2023

AbbieVie Buys ImmunoGen: A Groundbreaking $10.1 Billion Acquisition

In a stunning pre-market announcement, AbbVie Inc. has declared its intention to acquire ImmunoGen Inc., a prominent player in cancer…

By Rochdi Rais

Signup for the USA Herald
exclusive Newsletter